Applied Therapeutics, Inc. - COM (APLT)

Historical Portfolio Holders from Q2 2019 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
103M
Holdings value Q2 2024
$482M
Value change Q2 2024
+$37M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
92
Number of buys Q2 2024
6
Number of sells Q2 2024
-7
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 1.08M $9.17M +$597K $8.50 11
2024 Q2 103M $482M +$37M $4.67 96
2024 Q1 94M $639M +$241M $6.80 90
2023 Q4 61.4M $206M +$29.8M $3.35 82
2023 Q3 43M $107M +$29.1M $2.49 53
2023 Q2 31.5M $40.3M +$15.8M $1.28 37
2023 Q1 19.3M $15.6M -$232K $0.81 33
2022 Q4 19.7M $15.1M -$2.2M $0.76 36
2022 Q3 22.7M $21.1M -$3.75M $0.93 39
2022 Q2 26.7M $25.3M +$13M $0.95 45
2022 Q1 12.3M $26M -$34.5M $2.11 67
2021 Q4 14.9M $134M -$7.77M $8.95 66
2021 Q3 15.1M $251M -$6.26M $16.60 66
2021 Q2 15.4M $319M +$10.2M $20.78 67
2021 Q1 14.9M $279M +$51.4M $18.76 66
2020 Q4 12.1M $266M -$1.61M $22.01 68
2020 Q3 12.2M $253M -$6.26M $20.76 65
2020 Q2 11.4M $413M +$78.2M $36.15 70
2020 Q1 9.65M $315M +$155M $32.69 61
2019 Q4 4.99M $136M +$71.2M $27.28 45
2019 Q3 2.4M $26.3M +$2.27M $10.99 29
2019 Q2 2.2M $18.1M +$18.1M $8.24 13